auryxia Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Auryxia, and when can generic versions of Auryxia launch?
Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. There are fourteen patents protecting this drug.
This drug has one hundred and twenty-two patent family members in twenty-three countries.
The generic ingredient in AURYXIA is ferric citrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.
DrugPatentWatch® Generic Entry Outlook for Auryxia
There have been six patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for auryxia?
- What are the global sales for auryxia?
- What is Average Wholesale Price for auryxia?
Summary for auryxia
International Patents: | 122 |
US Patents: | 14 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 9 |
Patent Applications: | 552 |
Drug Prices: | Drug price information for auryxia |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for auryxia |
What excipients (inactive ingredients) are in auryxia? | auryxia excipients list |
DailyMed Link: | auryxia at DailyMed |
![auryxia drug patent expirations Drug patent expirations by year for auryxia](/p/graph/s/t/auryxia-patent-expirations.png)
![Drug Prices for auryxia](/p/graph/drug-price/auryxia.png)
Recent Clinical Trials for auryxia
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
USRC Kidney Research | Phase 3 |
Akebia Therapeutics | Phase 3 |
USRC Kidney Research | Phase 4 |
Pharmacology for auryxia
Drug Class | Parenteral Iron Replacement Phosphate Binder |
Mechanism of Action | Phosphate Chelating Activity |
US Patents and Regulatory Information for auryxia
auryxia is protected by fourteen US patents.
Patents protecting auryxia
Ferric citrate dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHORUS LEVELS
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Ferric citrate dosage forms
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CONTROL OF SERUM PHOSPHOROUS LEVELS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for auryxia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Keryx Biopharms | AURYXIA | ferric citrate | TABLET;ORAL | 205874-001 | Sep 5, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for auryxia
See the table below for patents covering auryxia around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 192545 | שימוש בברזל ציטרט בעל קצב פיזור של 2mg/cm2/min להכנת תרופה לטיפול בהסתיידות רקמה רכה ותכשירים רוקחיים המכילים ברזל ציטרט זה (Use of ferric citrate having a dissolution rate of at least approximately 2mg/cm2/min in the manufacture of a medicament for treating soft tissue calcification and pharmaceutical compositions comprising same ferric citrate) | ⤷ Sign Up |
Japan | 2009525276 | ⤷ Sign Up | |
Canada | 2272711 | PROCEDES DE TRAITEMENT DE L'INSUFFISANCE RENALE (METHOD FOR TREATING RENAL FAILURE) | ⤷ Sign Up |
Australia | 2007210090 | Method of treating chronic kidney disease | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |